Axcofarma SRL
The score of Axcofarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +32 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Axcofarma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 30,886 € | ||||
| Equity | 47,483 € | ||||
| Cash | 99,451 € | ||||
| EBITDA | 41,754 € | ||||
| Total assets | 489,172 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Axcofarma's financial analysis
- Solvency9.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Axcofarma
Axcofarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0889.949.363
- VAT number
- BE0889949363
- Peppol
- Registered · 0208:0889949363 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jun 2007
- Registered office
- 3590 Diepenbeek
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Axcofarma (SRL) has been based in Diepenbeek since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 30,886 € and equity of 47,483 €; its revenue is not published. Its solvency stands at 9.7%, below the median of its sector (44.2%).
Companies similar to Axcofarma
Companies in the same business, of comparable size and area, outside its group.
- DE MOL - Regnier Pharma Retail sale of pharmaceutical products Courcelles · balance sheet 642,568 €
- Pharmacie DU Sacre - Coeur Retail sale of pharmaceutical products Tournai · balance sheet €1.00m
- Wenduine Pharma Retail sale of pharmaceutical products De Haan · balance sheet €1.25m
- Smart Pharma Retail sale of pharmaceutical products Ixelles · balance sheet 483,477 €
- Apotheek Decloedt Retail sale of pharmaceutical products Torhout · balance sheet 512,604 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- B.D. Farma Retail sale of pharmaceutical products Zwalm · balance sheet 562,484 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
Frequently asked questions about Axcofarma
What is the revenue of Axcofarma?
Axcofarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Axcofarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0889949363 for Axcofarma, if the company is VAT-registered. Its company number (CBE) is 0889.949.363.
Where is the registered office of Axcofarma?
According to the CBE register, the registered office of Axcofarma is in 3590 Diepenbeek.
What is the equity of Axcofarma?
At the close of the 2025 financial year, the equity of Axcofarma amounts to 47,483 €, a solvency of 9.7% of total assets.
Who manages Axcofarma?
The register lists 2 active mandates at Axcofarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Axcofarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →